About Michael McFadden
Michael McFadden is a chief executive officer and director at Alpha Cognition.
Michael McFadden reports to the SEC as a director or officer of 2 public companies, including Urovant Sciences (UROV).
Michael McFadden first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Michael McFadden in the role, so the role may have started earlier or lasted longer.
Alpha Cognition Inc.
Chief Executive Officer and director
2021 – 2026 · Public company (ACOG)
Develops and sells medicines for people with Alzheimer's disease and other neurological conditions.
UL
Urovant Sciences Ltd.
CCO/Urovant Sciences, Inc
2018 – 2019 · Public company (UROV)
Key Colleagues at Startups
The people Michael McFadden works with at each company, as listed on that company's latest Form D.
Alpha Cognition Inc. · Form D, Nov 18, 2024
JH
John Havens
Director
PM
Phillip Mertz
Director
LM
Len Mertz
Director
HD
Henry Du
Executive officer
LA
Lauren D'Angelo
Chief Operating Officer
KC
Kenneth Cawkell
Director and Founder
RB
Rajeev Bakshi
Director